August 11, 2011 – Researchers have found more evidence supporting the role of fat around the heart in promoting atherosclerosis, according to a study published online in the journal Radiology.

August 10, 2011 — Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization – an invasive procedure that allows doctors to see the vessels and arteries leading to the heart – actually finds obstructive coronary artery disease (CAD) in people without known heart disease.

August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent System for the treatment of renal artery stenosis (narrowing of the main arteries supplying blood to the kidneys) in patients with uncontrolled hypertension (high blood pressure). Over time, narrowed kidney arteries can lead to kidney failure and increased risk of heart disease, stroke and peripheral artery disease. This approval is supported by the HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to Demonstrate Efficacy and Safety) study, which demonstrated that RX Herculink Elite is safe and effective in patients with renal artery stenosis and uncontrolled hypertension.

August 10, 2011 – In the 3.0 Tesla (T) magnetic resonance (MR) marketplace, patient compliance often impacts image quality and patient throughput. As the only 3.0T MR system designed to improve patient compliance and comfort while offering advanced radiology capabilities, Toshiba America Medical Systems Inc.’s new Vantage Titan 3.0T open-bore MR has received U.S. Food and Drug Administration (FDA) clearance. The new system is the only 3.0T MR offering patient-friendly features such as noise reduction, a wide and open bore, feet-first imaging and Toshiba’s proprietary contrast-free techniques.

August 9, 2011 — Boston Scientific Corp. said the U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a securities fraud case in connection with the 2004 recall of one of the company’s coronary stent systems.

August 9, 2011 — Acist Medical Systems Inc., a Bracco Group company and provider of advanced contrast injection system technology for cardiovascular angiography, announced that its’ Contrast Delivery System has been used to help diagnose and treat 10 million patients.

August 9, 2011 — The American Heart Association (AHA) 2011 annual scientific sessions will be held Nov. 12-16, in Orlando, Fla.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now